Patents by Inventor Jun-Jin Yoon

Jun-Jin Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OBLIGATE ANAEROBIC HUMAN INTESTINAL MICROBE FOR CANCER TREATMENT, AND USE THEREOF
    Publication number: 20240131081
    Abstract: The present disclosure relates to a novel Akkermansia strain and a use thereof. The novel Akkermansia HB03 strain (Akkermansia sp. HB03) provided in the present disclosure lacks toxic genes and thus does not cause side effects in vivo, and also exhibits excellent anti-cancer activity. Therefore, it can be widely used in the development of agents for preventing or treating cancer.
    Type: Application
    Filed: September 24, 2020
    Publication date: April 25, 2024
    Applicant: HEALTHBIOME
    Inventors: Jinhoi SONG, Jun Beom YOON, Mi Jin SON, Da Young SONG
  • Microstructure formulation techniques for botulinum toxin
    Patent number: 10792400
    Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
    Type: Grant
    Filed: November 20, 2019
    Date of Patent: October 6, 2020
    Assignees: Hugel Inc., Small Lab Co., Ltd.
    Inventors: Kyeong Yeop Moon, Chang Jin Lee, Dae Gun Kim, Dong Hoon Oh, Do Hyun Kang, Woo Ran Lee, Jeong Gyu Lee, Jun Jin Yoon, Juhyung Shin
  • Microstructure Formulation Techniques for Botulinum Toxin
    Publication number: 20200121831
    Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
    Type: Application
    Filed: November 20, 2019
    Publication date: April 23, 2020
    Applicants: Hugel Inc., Small Lab Co., Ltd.
    Inventors: Kyeong Yeop MOON, Chang Jin LEE, Dae Gun KIM, Dong Hoon OH, Do Hyun KANG, Woo Ran LEE, Jeong Gyu LEE, Jun Jin YOON, Juhyung SHIN
  • Microstructure formulation techniques for botulinum toxin
    Patent number: 10525111
    Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: January 7, 2020
    Assignees: Hugel, Inc., Small Lab Co., Ltd.
    Inventors: Kyeong Yeop Moon, Chang Jin Lee, Dae Gun Kim, Dong Hoon Oh, Do Hyun Kang, Woo Ran Lee, Jeong Gyu Lee, Jun Jin Yoon
  • Microstructure Formulation Techniques for Botulinum Toxin
    Publication number: 20190111119
    Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
    Type: Application
    Filed: October 12, 2017
    Publication date: April 18, 2019
    Inventors: Kyeong Yeop Moon, Chang Jin Lee, Dae Gun Kim, Dong Hoon Oh, Do Hyun Kang, Woo Ran Lee, Jeong Gyu Lee, Jun Jin Yoon
  • Preparing porous biodegradable polymeric scaffolds for tissue engineering using effervescent salts
    Patent number: 6586246
    Abstract: Three-dimensional porous biodegradable and biocompatible, polymeric scaffolds for tissue engineering are prepared by a method involving effervescing of an effervescent salt in a gel to result in a porous structure. A polymer is dissolved in an organic solvent to prepare a polymer solution of high viscosity. Optionally, the polymer solution is mixed with an organic solvent that does not dissolve the polymer to concentrate the solution. An effervescent salt is homogeneously mixed with the polymer solution to give a polymer/salt/organic solvent mixed gel. The organic solvent is removed from the mixed gel to produce an organic solvent-free polymer/salt gel slurry. The gel slurry is submerged in a hot aqueous solution or acidic solution to cause the salt to effervesce at room temperature to form a porous three-dimensional polymeric structure. The polymeric structure is washed with distilled water and freeze-dried to yield a scaffold that is suitable for cell or tissue culture.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: July 1, 2003
    Assignee: Innotech Medical, Inc.
    Inventors: Jun-Jin Yoon, Tae-Gwan Park, Yoon-Sung Nam